Sarepta Therapeutics Inc
Sector:
Industry:
115.62
-0.93
(-0.798%)
Volume:
641,222
52 week range:
55.25 - 159.89
Market Cap:
10.857B
Company Description:
sarepta therapeutics is a biopharmaceutical company focused on the discovery and development of unique rna-targeted therapeutics for the treatment of rare, infectious and other diseases. the company is primarily focused on rapidly advancing the development of its potentially disease-modifying dmd drug candidates, including its lead dmd product candidate, eteplirsen, designed to skip exon 51. sarepta is also developing therapeutics for the treatment of infectious diseases, such as drug-resistant bacteria and other rare human diseases. for more information, please visit us at www.sarepta.com.